Viral Entry Mechanisms: Fusion, Uncoating, and Nuclear Import

Entry routes for viral genome delivery

• Viruses face the same core problem: crossing the cell’s defensive barriers to deliver their genome where it needs to go. The plasma membrane is a major barrier; getting through is one of the most difficult steps in the viral life cycle.
• After attachment, many viruses must disassemble or rearrange the particle to release genetic material (we call this process decoding).
• For some viruses, simply entering the cytoplasm is not enough; some genomes must reach the nucleus to be replicated or transcribed.
• We will discuss three broad strategies for membrane traversal:
  • Fusion of the viral envelope with a cellular membrane (plasma membrane fusion) to release contents into the cytoplasm.
  • Fusion between the viral envelope and an endosomal membrane after endocytosis (endosomal fusion).
  • Entry of nonenveloped (non-membrane) viruses by disrupting the endosomal membrane and releasing the genome into the cytoplasm.
• Important distinction: enveloped viruses carry a lipid outer envelope; nonenveloped viruses do not.
• Binding to receptors and subsequent membrane fusion or endocytic uptake often requires additional steps or cofactors (co-receptors, pH changes, proteolytic cleavage) to become competent for fusion.

Entry by fusion with the plasma membrane (enveloped viruses)

• Concept: The viral membrane fuses directly with the host cell plasma membrane, merging the two lipid bilayers and releasing the viral genome into the cytoplasm.
• Examples and common features:
  • HIV (a retrovirus) uses membrane fusion at the plasma membrane; envelope glycoprotein complex (gp120/gp41) mediates attachment and fusion.
  • Paramyxoviruses (e.g., measles, mumps) also commonly enter by plasma membrane fusion and are often discussed in parallel with HIV.
  • All enveloped viruses have a lipid envelope; those with a membrane envelope generally fuse at the plasma membrane when triggered.
• Mechanistic components of class I fusion proteins (the major type responsible for this mode):
  • Fusion protein is a transmembrane protein with a transmembrane domain and a cytoplasmic tail; the external portion is responsible for receptor binding and fusion.
  • Cleavage is required for activity: the fusion protein is synthesized as a precursor (often called F0) and is proteolytically cleaved into two subunits, commonly F1 and F2. In paramyxoviruses, this is a critical maturation step. The uncleaved precursor (F0) does not function in fusion.
  • Fusion peptide: a short, highly hydrophobic region that inserts into the target (host) membrane to initiate fusion. It is initially tucked away inside the protein to avoid unfavorable exposure to water; it becomes exposed only at the right time.
  • Cleavage site is adjacent to the fusion peptide; after cleavage, the two pieces remain linked by a disulfide bond, forming a single functional complex (F1–F2) that can drive fusion when triggered.
  • Fusion proteins are trimers; the functional fusion unit is a trimer that undergoes large conformational changes.
  • Pre-fusion state is metastable and must be triggered at the correct time; the energy landscape has an activation barrier that must be overcome to proceed to the post-fusion six-helix bundle state.
  • Fusion peptide is initially shielded within the protein and becomes exposed only after triggering; this helps prevent premature fusion.
  • Heptad repeats (HR) A and B (HRA and HRB) form coiled-coil motifs that, upon conformational change, drive the fusion core together, pulling the viral and cellular membranes into proximity and ultimately fusing them.
  • The post-fusion state features a six-helix bundle (three HR1 helices and three HR2 helices) that stabilizes the fused membranes in a tight, irreversible configuration.
• Structural orientation example: In paramyxoviruses, the typical architecture includes an attachment protein (binds the receptor) and a separate fusion protein (F) with F1 and F2 subunits; the fusion peptide is at the end of F2 near the cleavage site.
• Triggering and timing: Fusion must be tightly regulated; premature fusion wastes the fusion protein (irreversible step) and offers no second chance. Triggers can include receptor binding by the attachment protein or signaling between attachment and fusion proteins.

Entry via endocytosis and endosomal fusion (membrane-enveloped viruses)

• Concept: Viruses with envelopes can be taken up into cells by endocytosis, ending up in endosomes. Fusion then occurs between the viral envelope and the endosomal membrane.
• Outcome: The viral genome (or core) is released into the cytoplasm, despite the endosomal barrier, through membrane fusion at the endosomal membrane.
• Examples and notes:
  • Some enveloped viruses use endosomal fusion rather than plasma membrane fusion as their primary route.
  • Class II fusion proteins (see below) are typical in many flaviviruses (e.g., Dengue, West Nile) and alphaviruses; these often rely on endosomal acidification as the fusion trigger.
• Class II fusion proteins (characteristics and contrast with Class I):
  • These proteins are also embedded in the viral membrane and function as trimers, but they do not use a proteolytic cleavage to generate an exposed fusion peptide.
  • They generally have a fusion loop at the end of the protein instead of a separate fusion peptide; this loop interacts with the target membrane to initiate fusion.
  • They exist as dimers in the prefusion state (often a “dimer of dimers” that rearranges to a trimer in fusion), and the conformational change involves a different set of structural motifs (beta sheets rather than alpha-helix HR repeats).
  • They often require an accessory protein to shield the fusion loop in the prefusion state; upon triggering, the accessory protein dissociates, exposing the fusion loop to insert into the host membrane.
• Example virus (class II): Semliki Forest virus (SFV) and related flaviviruses/to all togaviruses;
  • E proteins (e.g., E1) form heterodimers with a companion protein (e.g., E2) that shields the fusion loop.
  • Upon low pH trigger in the endosome, the accessory protein (E2) dissociates, exposing the fusion loop to the host membrane.
  • The E1/E2 complex then rearranges: the E1 fusion loop inserts into the host membrane, and the protein folds to pull membranes together, ultimately forming a fusion-ready state and merging the two membranes.
  • The fusion process forms a structure analogous to a post-fusion hairpin; a trimer of dimers becomes a functional trimer that drives membrane apposition.
• General mechanism similarities with class I: In both cases, the fusion peptide/loop inserts into the target membrane, the protein folds to bring the membranes together, and a stable post-fusion structure drives merger of the two lipid bilayers into a single membrane.
• Key difference: Class II proteins do not rely on a cleavage-generated fusion peptide, and they undergo a different oligomeric rearrangement (dimer of dimers to trimer) and use a fusion loop instead of a free fusion peptide.
• Triggering and timing: Endosomal pH drop is a major trigger for class II fusion and for many flaviviruses; the pH sensitivity is often tuned so that fusion occurs after proper receptor engagement and endocytic trafficking.

Non-enveloped (non-membrane) viruses: endosomal escape without fusion

• Strategy: Viruses lacking a lipid envelope must disrupt the endosomal membrane to release their genome into the cytoplasm.
• Example virus: Adenovirus (DNA virus, icosahedral capsid, nonenveloped)
  • Entry pathway: Attachment to CAR receptor via fiber knob; co-receptor engagement with integrins; internalization by receptor-mediated endocytosis.
  • Endosomal stage: In the low pH endosome, the particle begins to disassemble; fibers and penton base at the vertices are released, yielding a capsid remnant that is looser and more prone to endosomal escape.
  • Endosomal escape: Penton bases released from the capsid can function as membrane-active proteins that disrupt the endosomal membrane; this rupture allows the capsid remnant to escape into the cytoplasm.
  • Post-escape trafficking: The capsid remnant docks on microtubules and is transported to the nucleus; genome entry into the nucleus follows.
• Key point: Because there is no fusion event, entry relies on physical disruption of the endosomal membrane and subsequent trafficking to the nucleus without a true fusion step.

Fusion-triggering logic and timing across virus types

• A good trigger must coordinate with receptor engagement and endosomal maturation; once fusion initiates, the process is generally irreversible and consumes the fusion protein’s one opportunity.
• Triggering strategies by virus category:
  • Receptor/co-receptor binding as trigger (e.g., HIV uses primary receptor binding to trigger gp41 fusion; co-receptor engagement further stabilizes the triggered state).
  • Endosomal low pH as trigger (e.g., influenza HA and flavivirus class II fusion proteins rely on acidic endosomal pH to trigger conformational changes after endocytosis).
  • In some paramyxoviruses, receptor binding to the attachment protein conveys the signal to the fusion protein to trigger, since there is no separate co-receptor.
• Specific example details:
  • HIV (class I): gp120 (attachment) binds CD4 and a co-receptor (CCR5 or CXCR4). This binding triggers gp41 (fusion subunit) to expose its fusion peptide and begin the refolding to drive fusion.
  • Paramyxoviruses (class I): attachment protein binds receptor; fusion protein (F) executes the conformational change after a signal is transmitted from the attached receptor-binding event.
  • Influenza (class I): HA is cleaved into HA1/HA2; low endosomal pH triggers the fusion; uncoating requires the proton channel M2 to equilibrate pH across the viral envelope so that matrix protein interactions can break and genome segments can be released.

Influenza virus specifics: uncoating and nucleus delivery

• Genome organization: Influenza is an eight-segment, negative-sense RNA virus; genome segments are each associated with nucleoprotein (NP) and together form ribonucleoprotein complexes.
• Key players:
  • Hemagglutinin (HA): class I fusion protein; trimer; HA1 is receptor-binding; HA2 contains the fusion machinery; HA is cleaved into HA1/HA2 just after synthesis (maturation step).
  • Neuraminidase (NA): helps release virions from the cell surface; not directly discussed here but part of the influenza particle.
  • Matrix protein M1: lines the inner surface of the viral envelope and interacts with NP-coated RNA segments to assemble the virion.
  • Nuclear import and trafficking: NP-containing RNPs have nuclear localization signals; the NP-RNA complex can be transported through the nuclear pore complex (NPC) using the host’s import machinery (importins alpha/beta).
• Uncoating and genome release in the endosome:
  • Endosomal acidification triggers HA fusion between viral and endosomal membranes.
  • A separate, critical step is uncoating: low pH inside the endosome must be communicated to the interior of the virion to break interactions that keep NP-RNA bound to M1.
  • The virus accomplishes interior acidification via the M2 proton channel (an ion channel in the viral membrane) that allows protons to pass from the endosome into the virion interior.
  • Without M2, the NP-M1 interactions would not break efficiently, and genome segments would remain bound to the matrix and fail to reach the nucleus.
• Consequence: genome segments become available for nuclear import; influenza genome segments must be transported to the nucleus where replication and transcription occur for this virus family.

Nuclear import and genome trafficking into the nucleus (broad overview)

• Not all viruses need to deliver their genome to the nucleus. Many RNA viruses replicate in the cytoplasm and do not use the host nuclear machinery.
• General nuclear import concepts:
  • Nuclear localization signals (NLS) on viral proteins allow recognition by importin proteins (e.g., importin-α and importin-β) that mediate docking at the nuclear pore complex (NPC).
  • Small proteins (< ~40 kDa) may diffuse through NPCs by simple diffusion without an NLS.
  • Larger complexes require active, energy-dependent transport via the importin machinery to cross the NPC.
• Influenza: genome delivered as a ribonucleoprotein complex with NP that contains NLSs; the entire NP-coated RNA segment complex is transported into the nucleus via importins and NPC machinery.
• DNA viruses (common nuclear import strategies):
  • Herpesviruses (large DNA viruses): the incoming nucleocapsid docks at the nuclear pore; the genome exits the capsid through a nuclear pore opening (portal is used during packaging as well) and enters the nucleus.
  • Adenoviruses (non-enveloped, large DNA virus): the intact particle is too large to pass through the pore; upon endosomal processing and disassembly, a capsid remnant becomes capable of docking and delivering the genome to the nucleus via pore-associated or nearby openings.
  • Parvoviruses (very small DNA viruses): certain parvoviruses can enter through the nuclear pore due to their small size; others disrupt the nuclear membrane at a site near the pore to create an opening so the particle can enter and then release its genome inside.

Genome delivery strategies by virus type (illustrative examples)

• Influenza virus (RNA virus, nuclear import):
  • Genome in the form of NP-coated RNA segments; each segment has an NLS; assembly into vRNPs (viral ribonucleoproteins) allows nuclear import via NPC machinery.
  • Eight segments: $8$ segments in total, each associated with NP and other components for replication and transcription inside the nucleus.
• Herpes simplex virus (DS DNA virus):
  • Large capsid enters cytoplasm; docking at the NPC; genome released through the portal-like opening at the nucleus into the nucleus.
  • This “portal opening” is a specialized feature of the capsid that was involved in genome entry during assembly and is repurposed for genome exit into the nucleus.
• Adenovirus (nonenveloped DNA virus):
  • Non-enveloped particle; after endosomal entry and disassembly, capsid remnant docks to the nuclear pore and genome is released into the nucleus through the pore.
• Parvoviruses (small DNA viruses):
  • Docking at nuclear pore; may disrupt the nuclear membrane nearby to create a channel for the genome to enter the nucleus; the entire particle may be delivered into the nucleus and genome released there.
• Adenovirus vs Herpes vs Parvovirus contrasts:
  • Size and pore constraints: Herpes can eject genome through the pore; Adenovirus disassembles to a remnant that allows genome release; Parvovirus may be small enough to pass or disrupt membrane at the pore to gain entry.
  • Portal-specific openings (herpes) vs non-portal strategies (adenovirus, parvovirus).

Connections to broader principles and real-world relevance

• A common solution to the problem of merging two membranes (virus envelope with cellular membrane) appears repeatedly across diverse virus families: membrane fusion driven by a fusogenic protein that undergoes a large conformational change to bring the two lipid bilayers into close apposition and merge them.
• The two major families of fusion proteins (class I and class II) represent parallel evolutionary solutions to the same biophysical problem:
  • Class I fusion proteins: typically form trimers, have a proteolytic cleavage step generating a fusion peptide, and rely on alpha-helical coiled-coil interactions (heptad repeats HR1/HR2) to form a six-helix bundle that drives membrane fusion.
  • Class II fusion proteins: typically form dimers that rearrange into trimers; use a fusion loop rather than a free fusion peptide; often require a dissociable accessory protein to shield the fusion loop in the prefusion state; rely on a different set of structural motifs (beta-sheet–rich core) to drive fusion.
• The same core problem (merging two lipid bilayers) has led to convergent strategies across very different virus families, illustrating parallel evolution and how physical constraints shape biological solutions.
• The fusion-triggering signals vary across viruses:
  • Receptor binding or co-receptor engagement can provide a precise cue that fusion should occur now.
  • Endosomal acidification provides a universal and robust internal cue for endosomal-entry viruses, ensuring fusion occurs only after proper cellular trafficking.
  • Some viruses require a combination of cues (e.g., receptor engagement plus low pH) before fusion proceeds.
• The uncoating problem in influenza highlights that successful entry often requires coordinated steps beyond fusion, including disassembly of the particle to release genomes and make them accessible for replication in the nucleus or cytoplasm.
• Drug-related relevance: understanding these processes informs antiviral strategies; for example, targeting M2 in influenza blocks uncoating, illustrating how blocking a specific step in entry can inhibit infection.

Quick references to common numerical and structural concepts mentioned

• Genome segmentation (influenza): $8$ segments.
• Cleavage and subunit naming in class I fusion proteins: precursor $F0$ cleaved into $F1$ and $F2$; some proteins retain a disulfide linkage between $F1$ and $F_2$ after cleavage.
• Fusion core: six-helix bundle formed by three copies each of HR1 and HR2 (three HR1 helices + three HR2 helices).
• Fusion peptide location: hydrophobic region adjacent to the cleavage site; tucked into the interior of the prefusion protein until triggered.
• Fusion loop: the analogous hydrophobic region in class II proteins.
• Nuclear import size constraint: proteins smaller than ~40 kDa can diffuse through the nuclear pore; larger complexes require active transport via NLS and importins.

Summary of key takeaways

• Viruses employ three main entry strategies depending on whether they possess a membrane, and on the cellular route taken (plasma membrane vs endosome vs nucleus).
• Enveloped viruses primarily use membrane fusion to deliver the genome, either at the plasma membrane (class I fusion proteins like HIV and paramyxoviruses) or from within endosomes (class II fusion proteins in flaviviruses/alphaviruses).
• Non-enveloped viruses rely on disassembly and endosomal disruption to release genomes into the cytoplasm.
• Fusion proteins operate through large conformational changes that bring two membranes together, often forming a stable post-fusion six-helix bundle (class I) or a similar functional architecture in class II via a fusion loop.
• Triggers for fusion are diverse: receptor binding, co-receptor engagement, and endosomal low pH, with timing being critical to avoid wasted fusion attempts.
• Once in the cytoplasm, many RNA viruses stay there; DNA viruses frequently target the nucleus, using cellular import machinery or nuclear pore interactions to deliver genomes (and sometimes genome segments) into the nucleus.
• Influenza uniquely couples membrane fusion with genome uncoating through the M2 proton channel to enable genome release and subsequent nuclear import for replication.
• Adenovirus and parvoviruses illustrate how non-enveloped viruses accomplish genome delivery to the nucleus via endosomal disruption and nuclear pore/ nuclear membrane strategies, respectively.

If you’d like, I can convert this into a printable study sheet or tailor a quiz-style version with core questions and answers to test essential concepts from this content.